Regular Meeting of the

INDEPENDENT CITIZENS OVERSIGHT COMMITTEE (“ICOC”)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To Government Code section 11346.5(a)(17)
and

The CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Date: Tuesday, April 28, 2009

Time:  4:30 PM – 9:00 PM (Estimated)

• Westin Bonaventure
  404 South Figueroa Street
  Los Angeles, CA 90071

• Stanford University
  Clark Center
  318 Campus Drive
  Stanford, CA 94305

• ValleyCare Health System
  5575 West Las Positas Blvd., Suite 300
  Pleasanton, CA 94588

• UC Davis School of Medicine
  Education Building
  4610 X Atreet, Conference Room 4202C

Date: Wednesday, April 29, 2009

Time:  8:30 AM – 5:00 PM (Estimated)

Locations:

• Stanford University
  Clark Center
  318 Campus Drive
  Stanford, CA 94305

• ValleyCare Health System
  5575 West Las Positas Blvd., Suite 300
  Pleasanton, CA 94588

• UC Davis School of Medicine
  Education Building
  4610 X Street, Conference Room 4202C

Open Session

1. Call to Order.
2. Pledge of Allegiance.
3. Roll Call.

   [Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

Consent Items

4. Approval of minutes from August 12-13, September 25, December 9-10, 2008; and January 29th-30th and March 12, 2009 ICOC meetings.
5. Approval of technical amendments to Grants Administration Policy for Academic and Non-Profit Institutions.

REPORTS

6. Chairman’s Report.
7. President’s Report.
8. Update on CIRM grantee progress report monitoring.
9. Communications report, including but not limited to update on statewide education program.

ACTION ITEMS

10. Consideration of recommendations from Grants Working Group on Early Translational Research Awards applications.
    1. Extraordinary Petition: TR1-01229
    2. Extraordinary Petition: TR1-01232
    3. Extraordinary Petition: TR1-01266
    4. Extraordinary Petition: TR1-01267

Closed Session

11. Discussion of confidential intellectual property or work product and prepublication, confidential scientific research or data relating to Early Translational Research Awards applications. (Health & Safety Code 125290.30(d) (3) (B) and (C)).

Public report of any action taken, if necessary, during closed session.

Action Items

12. Consideration of new scientific members for Grants Working Group.
13. Consideration of evaluation procedures for performance evaluation for Chair, Vice-Chair, and President.
14. Consideration of federal legislation, H.R. 1427 and H.R. 1548.
    1. Side-by-side comparison of H.R. 1427 and H.R. 1548
15. Consideration of Request for CIRM to co-sponsor the annual meeting of the International Society for Stem Cell Research.
16. Consideration of comments on NIH draft guidelines for research utilizing human embryonic stem cells.
    1. ATTACHMENT B: Comparison
    2. ATTACHMENT C: Certification Form

Discussion Items

17. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.